Literature DB >> 32307664

Paraneoplastic basal ganglia encephalitis associated with anti-CV2/CRMP-5 and anti-Yo antibodies in a patient with non-small-cell lung cancer.

Aigli Vakrakou1, Vasilios C Constantinides2, George Velonakis3, John S Tzartos1,4, Leonidas Stefanis1, Elisabeth Kapaki1, George P Paraskevas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32307664     DOI： 10.1007/s10072-020-04399-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  13 in total

Review 1.  Autoantibody-associated movement disorders.

Authors:  Shekeeb S Mohammad; Sudarshini Ramanathan; Fabienne Brilot; Russell C Dale
Journal:  Neuropediatrics       Date:  2013-11-07       Impact factor: 1.947

2.  Chorea resulting from paraneoplastic striatal encephalitis.

Authors:  T Tani; Y Piao; S Mori; N Ishihara; K Tanaka; K Wakabayashi; H Takahashi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

3.  Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer.

Authors:  Nese Dericioglu; Rahsan Gocmen; Ersin Tan
Journal:  Clin Neurol Neurosurg       Date:  2018-05-16       Impact factor: 1.876

4.  Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.

Authors:  John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair L Wood; Ikuo Tsunoda; Noel G Carlson
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

Review 5.  Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience.

Authors:  Maria Claudia Vigliani; Jerome Honnorat; Jean-Christophe Antoine; Roberta Vitaliani; Bruno Giometto; Dimitri Psimaras; Federica Franchino; Carlotta Rossi; Francesc Graus
Journal:  J Neurol       Date:  2011-05-11       Impact factor: 4.849

Review 6.  Paraneoplastic movement disorders.

Authors:  Karolina Popławska-Domaszewicz; Jolanta Florczak-Wyspiańska; Wojciech Kozubski; Sławomir Michalak
Journal:  Rev Neurosci       Date:  2018-09-25       Impact factor: 4.353

7.  Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.

Authors:  J Honnorat; S Cartalat-Carel; D Ricard; J Ph Camdessanche; A F Carpentier; V Rogemond; F Chapuis; M Aguera; E Decullier; A M Duchemin; F Graus; J C Antoine
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-17       Impact factor: 10.154

8.  Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.

Authors:  Steven Vernino; Paul Tuite; Charles H Adler; James F Meschia; Bradley F Boeve; Peter Boasberg; Joseph E Parisi; Vanda A Lennon
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

9.  Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.

Authors:  John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair Wood; Stacey L Clardy; Ikuo Tsunoda; Noel G Carlson
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 10.  Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Authors:  Bettina Balint; Angela Vincent; Hans-Michael Meinck; Sarosh R Irani; Kailash P Bhatia
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.